97273771 - VISLUCI

Information

  • Trademark
  • 97273771
  • Serial Number
    97273771
  • Filing Date
    February 18, 2022
    3 years ago
  • Transaction Date
    December 19, 2024
    4 months ago
  • Status Date
    December 18, 2024
    4 months ago
  • Published for Opposition Date
    April 04, 2023
    2 years ago
  • Location Date
    January 30, 2024
    a year ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    SHOOR, AMIT
  • Attorney Name
    CONNIE ELLERBACH
    Law Office Assigned Location Code
    M80
  • Owners
Mark Drawing Code
4
Mark Identification
VISLUCI
Case File Statements
  • GS0051: Diagnostic agents, preparations, and substances for medical purposes; Imaging and therapeutic agents for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; Preparations and substances for medical purposes for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; None of the foregoing for detecting, diagnosing, or treating diseases originating in the eye, with the exception of melanoma; medical diagnostic reagents; reagents for medical use; imaging and detection agents for diagnosing and monitoring cancer, and oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders
  • GS0421: Medical research; scientific research; product research and development; product development in the field of the detection, location, and treatment of diseases; design and development of therapies, diagnostic agents, imaging agents, and medical devices for detecting, locating, and treating cancer and other diseases
Case File Event Statements
  • 8/24/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/22/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/23/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/19/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/24/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/24/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/24/2023 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/24/2023 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/25/2023 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/28/2023 - 2 years ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/28/2023 - 2 years ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/28/2023 - 2 years ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/28/2023 - 2 years ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/28/2023 - 2 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/15/2023 - 2 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/4/2023 - 2 years ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/4/2023 - 2 years ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/2/2023 - a year ago
    18 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 8/1/2023 - a year ago
    19 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 12/16/2023 - a year ago
    21 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 1/30/2024 - a year ago
    23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/16/2023 - a year ago
    20 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 12/16/2023 - a year ago
    22 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 7/10/2024 - 9 months ago
    24 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/10/2024 - 9 months ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/10/2024 - 9 months ago
    26 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 7/10/2024 - 9 months ago
    25 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/18/2024 - 4 months ago
    28 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/18/2024 - 4 months ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/18/2024 - 4 months ago
    29 - SOU EXTENSION 2 FILED Type: EXT2
  • 12/18/2024 - 4 months ago
    30 - SOU EXTENSION 2 GRANTED Type: EX2G